KalVista Pharmaceuticals, Inc. KALV | $74.12M | 14.62 | 6.25M | +52.7% | +$25.58M | 3.6 | |
Apogee Therapeutics, Inc. APGE | $564.38M | 14.53 | 8.49M | 0% | +$0 | 27.41 | |
Mersana Therapeutics, Inc. MRSN | $50.75M | 9.26 | 11.33M | 0% | +$0 | 2.47 | |
Enliven Therapeutics, Inc. ELVN | $70.82M | 8.56 | 4.03M | +36.26% | +$18.85M | 3.44 | |
4D Molecular Therapeutics, Inc. FDMT | $140.18M | 8.51 | 4.4M | +28.5% | +$31.09M | 6.81 |